 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
|
|
MERGE HEALTHCARE INTRODUCES PET/CT
WORKSTATION SOFTWARE
Dual modality solution maximizes PET/CT reading and reporting through advanced imaging capabilities combined with fast and efficient workflow
Milwaukee, WI, April 5, 2007 - Merge Healthcare (NASDAQ: MRGE; TSX: MRG), a leading provider of medical imaging software and services, today announced the release of its Merge PET/CT Workstation™ software. Designed to readily accommodate standard methods used by radiologists to read images obtained by PET (Positron Emission and Tomography) and CT (Computed Tomography), Merge PET/CT Workstation is a vendor-neutral solution that maximizes digital reading with easy-to-use controls for advanced imaging and streamlined reporting.
"With PET/CT, health care specialists can view physiological activity in conjunction with anatomical location," said Chrysti Bowers, RTRM, Director of Clinical Solutions for Merge Healthcare. "Yet this clinical advantage can be lessened by the challenges posed by fusing the large PET and CT data sets. PET/CT practitioners from radiology, nuclear medicine and oncology must feel confident that technology will optimize clinical effectiveness while also maximizing workflow efficiency. Our new Merge PET/CT workstation delivers on both fronts."
For premium clinical effectiveness, Merge PET/CT has incorporated reading tools such as 3D volume rendering and hot-spot scout, and comprehensive reporting tools such as SUV (Standard Uptake Value) calculations and configurable colormaps. Workflow is enhanced by layouts that mimic PACS (Picture Archiving and Communication Systems) layouts split across dual monitors in panoramic mode. This allows simultaneous review of CT, PET Corrected, PET Uncorrected, PET/CT Fused and MIP images. Rigid registration between images allows simultaneous navigation through all data sets. Merge PET/CT also allows for DICOM connectivity to PACS solutions for easier image receiving and storage.
"Many physicians who read CT studies have been forced to practice directly on PET/CT consoles – requiring them to be at a location where the modality is located," Bowers explains. "As a vendor-neutral application, Merge PET/CT Workstation can be used as a stand-alone workstation, or it can be integrated easily into a DICOM-compliant PACS environment. With this software, PET/CT images can be available immediately at a centralized workstation where other modalities are read -- saving time, minimizing frustration and enabling efficient reporting for PET/CT studies. Users of this solution recognize a real paradigm shift we’re creating for molecular imaging."
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.mergehealthcare.com.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
